Display options
Share it on

Mol Cytogenet. 2014 Jan 28;7(1):9. doi: 10.1186/1755-8166-7-9.

Induction of polyploidy by nuclear fusion mechanism upon decreased expression of the nuclear envelope protein LAP2β in the human osteosarcoma cell line U2OS.

Molecular cytogenetics

Shirley Oren Ben-Shoshan, Amos J Simon, Jasmine Jacob-Hirsch, Sigal Shaklai, Nurit Paz-Yaacov, Ninette Amariglio, Gideon Rechavi, Luba Trakhtenbrot

Affiliations

  1. Sheba Cancer Research Center, Chaim Sheba Medical Center, 52621, Tel-Hashomer, Israel.
  2. Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
  3. Institute of Hematology, Chaim Sheba Medical Center, 52621, Tel-Hashomer, Israel.

PMID: 24472424 PMCID: PMC3926685 DOI: 10.1186/1755-8166-7-9

Abstract

BACKGROUND: Polyploidy has been recognized for many years as an important hallmark of cancer cells. Polyploid cells can arise through cell fusion, endoreplication and abortive cell cycle. The inner nuclear membrane protein LAP2β plays key roles in nuclear envelope breakdown and reassembly during mitosis, initiation of replication and transcriptional repression. Here we studied the function of LAP2β in the maintenance of cell ploidy state, a role which has not yet been assigned to this protein.

RESULTS: By knocking down the expression of LAP2β, using both viral and non-viral RNAi approaches in osteosarcoma derived U2OS cells, we detected enlarged nuclear size, nearly doubling of DNA content and chromosomal duplications, as analyzed by fluorescent in situ hybridization and spectral karyotyping methodologies. Spectral karyotyping analyses revealed that near-hexaploid karyotypes of LAP2β knocked down cells consisted of not only seven duplicated chromosomal markers, as could be anticipated by genome duplication mechanism, but also of four single chromosomal markers. Furthermore, spectral karyotyping analysis revealed that both of two near-triploid U2OS sub-clones contained the seven markers that were duplicated in LAP2β knocked down cells, whereas the four single chromosomal markers were detected only in one of them. Gene expression profiling of LAP2β knocked down cells revealed that up to a third of the genes exhibiting significant changes in their expression are involved in cancer progression.

CONCLUSIONS: Our results suggest that nuclear fusion mechanism underlies the polyploidization induction upon LAP2β reduced expression. Our study implies on a novel role of LAP2β in the maintenance of cell ploidy status. LAP2β depleted U2OS cells can serve as a model to investigate polyploidy and aneuploidy formation by nuclear fusion mechanism and its involvement in cancerogenesis.

References

  1. Genes Chromosomes Cancer. 2001 Jul;31(3):201-8 - PubMed
  2. PLoS One. 2013 Jun 26;8(6):e66731 - PubMed
  3. BMC Med. 2011 Mar 26;9:28 - PubMed
  4. Cell Mol Life Sci. 2006 Feb;63(3):316-32 - PubMed
  5. Curr Opin Genet Dev. 2007 Apr;17(2):157-62 - PubMed
  6. Curr Opin Cell Biol. 2012 Feb;24(1):71-8 - PubMed
  7. Curr Issues Mol Biol. 2001 Jul;3(3):67-70 - PubMed
  8. Cancer Res. 2008 Oct 1;68(19):8146-55 - PubMed
  9. Proc Natl Acad Sci U S A. 2009 Jun 9;106(23):9385-90 - PubMed
  10. Cell Cycle. 2012 Aug 1;11(15):2864-75 - PubMed
  11. Nat Rev Mol Cell Biol. 2005 Jan;6(1):21-31 - PubMed
  12. J Cell Sci. 2005 Sep 1;118(Pt 17):4017-25 - PubMed
  13. Cold Spring Harb Perspect Biol. 2010 Nov;2(11):a000547 - PubMed
  14. Nat Protoc. 2009;4(1):44-57 - PubMed
  15. Cell. 1993 Jul 2;73(7):1267-79 - PubMed
  16. J Cell Biol. 2003 Jan 20;160(2):177-88 - PubMed
  17. Cell Death Differ. 2011 Sep;18(9):1403-13 - PubMed
  18. J Cell Sci. 2000 Oct;113 Pt 19:3473-84 - PubMed
  19. Carcinogenesis. 2006 Feb;27(2):337-43 - PubMed
  20. J Cell Biol. 2009 Jul 27;186(2):183-91 - PubMed
  21. Nat Rev Cancer. 2008 May;8(5):377-86 - PubMed
  22. Eur J Cell Biol. 2003 Mar;82(3):143-53 - PubMed
  23. Lancet Oncol. 2005 Dec;6(12):988-93 - PubMed
  24. FEBS J. 2007 Mar;274(6):1383-92 - PubMed
  25. Neoplasia. 2012 Nov;14(11):1057-66 - PubMed
  26. Neoplasia. 2008 Oct;10(10):1057-65 - PubMed
  27. J Cell Biol. 1999 Mar 22;144(6):1083-96 - PubMed
  28. Annu Rev Cell Dev Biol. 2011;27:585-610 - PubMed
  29. J Cell Mol Med. 2009 Jun;13(6):1059-85 - PubMed
  30. Cancer Cell. 2012 Jun 12;21(6):765-76 - PubMed
  31. Genome Biol. 2003;4(5):P3 - PubMed
  32. Nat Rev Cancer. 2012 Feb 16;12(3):196-209 - PubMed
  33. Cancer Res. 2009 Nov 15;69(22):8536-9 - PubMed
  34. Adv Enzyme Regul. 2009;49(1):157-66 - PubMed
  35. Nat Rev Mol Cell Biol. 2009 Mar;10(3):178-91 - PubMed
  36. Genes Chromosomes Cancer. 2003 Jan;36(1):7-16 - PubMed
  37. J Cell Sci. 2008 Dec 1;121(Pt 23):3859-66 - PubMed
  38. J Cell Biol. 1997 Dec 1;139(5):1077-87 - PubMed
  39. Oral Oncol. 2008 Apr;44(4):369-82 - PubMed
  40. Cancer Cell. 2003 May;3(5):445-8 - PubMed
  41. Neoplasia. 2008 Jun;10(6):604-12 - PubMed
  42. J Cell Sci. 2001 Sep;114(Pt 18):3297-307 - PubMed

Publication Types